DeepMed Research

Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Efficacy of Nanodropper-mediated Topical Anesthetic

Phase 4

Recruiting

Conditions: Corneal Diseases
Effectiveness of Microdrops

First Posted Date: 2024-10-15

Last Posted Date: 2025-01-13

Lead Sponsor: Columbia University

Target Recruit Count: 41

Registration Number: NCT06636708

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Synbiotic Therapy for NP-PASC

Not Applicable

Recruiting

Conditions: Post-Acute COVID-19 Syndrome
Long COVID-19

Interventions: Dietary Supplement: Synbiotic IVS-1
Dietary Supplement: Maltodextrin

First Posted Date: 2024-10-01

Last Posted Date: 2025-01-16

Lead Sponsor: Columbia University

Target Recruit Count: 30

Registration Number: NCT06620406

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Discogen for Low Back Pain

Not Applicable

Recruiting

Conditions: Disc Herniation

Interventions: Device: Discogen Low pulsed ultrasound treatment
Device: Discogen Sham Treatment

First Posted Date: 2024-09-25

Last Posted Date: 2025-03-05

Lead Sponsor: Columbia University

Target Recruit Count: 40

Registration Number: NCT06611397

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Diazoxide Suppression Test P&F Study

Phase 1

Recruiting

Conditions: Insulin Resistance
Hyperinsulinemia
Obesity

Interventions: Drug: Diazoxide, 3 mg/kg per dose

First Posted Date: 2024-09-23

Last Posted Date: 2025-01-08

Lead Sponsor: Columbia University

Target Recruit Count: 10

Registration Number: NCT06606327

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Temporal Interference Stimulation for Social Cognition

Not Applicable

Recruiting

Conditions: Healthy Controls

Interventions: Device: Transcranial Interference Stimulation (tIS)
Other: Sham tIS

First Posted Date: 2024-09-23

Last Posted Date: 2025-03-07

Lead Sponsor: Columbia University

Target Recruit Count: 30

Registration Number: NCT06607432

Locations: 🇺🇸
Columbia University Irving Medical Center/NewYork-Presbyterian Hospital (CUIMC/NYPH), New York, New York, United States

Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season

Not Applicable

Active, not recruiting

Conditions: Influenza
COVID-19
Vaccination Hesitancy

Interventions: Behavioral: Text message influenza and COVID-19 vaccine reminders
Behavioral: Text message influenza vaccine reminders
Behavioral: Text message COVID-19 vaccine reminders

First Posted Date: 2024-09-19

Last Posted Date: 2025-01-16

Lead Sponsor: Columbia University

Target Recruit Count: 50000

Registration Number: NCT06603090

Locations: 🇺🇸
American Academy of Pediatrics, Itasca, Illinois, United States
🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

and more 1 locations

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Phase 2

Recruiting

Conditions: Mild Cognitive Impairment (MCI)
Cognitive Training

Interventions: Other: Cognitive Training

First Posted Date: 2024-09-19

Last Posted Date: 2025-01-10

Lead Sponsor: Columbia University

Target Recruit Count: 240

Registration Number: NCT06601933

Locations: 🇺🇸
Columbia University CRR, New York, New York, United States
🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Graded Insulin Suppression Test P&F

Phase 1

Recruiting

Conditions: Insulin Resistance
Hyperinsulinemia
Obesity
Healthy

Interventions: Drug: Insulin regular, 2.0-3.2 mU/m2/min (euinsulinemia)
Drug: Insulin regular, 32 mU/m2/min (hyperinsulinemia)
Drug: Octreotide Acetate, 6-45 ng/kg/min
Drug: Dextrose 20 % in Water
Drug: Glucagon, 0-0.5 ng/kg/min

First Posted Date: 2024-09-19

Last Posted Date: 2025-01-16

Lead Sponsor: Columbia University

Target Recruit Count: 15

Registration Number: NCT06592261

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau

Phase 1

Not yet recruiting

Conditions: Alzheimer Disease, Early Onset

Interventions: Device: Neuronavigation-guided single-element focused ultrasound transducer
Drug: Lumason
Other: Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents
Radiation: Positron Emission Tomography (PET)
Drug: Amyvid
Drug: MK-6240
Drug: Dotarem
Diagnostic Test: Blood draw
Device: UR5e
Diagnostic Test: Urine test

First Posted Date: 2024-09-19

Last Posted Date: 2025-05-11

Lead Sponsor: Columbia University

Target Recruit Count: 6

Registration Number: NCT06600880

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Body Electric: a Pragmatic Trial Evaluating the Viability of Movement Breaks

Not Applicable

Completed

Conditions: Sedentary Behavior

Interventions: Behavioral: Sedentary Breaks

First Posted Date: 2024-09-12

Last Posted Date: 2024-09-19

Lead Sponsor: Columbia University

Target Recruit Count: 20217

Registration Number: NCT06592209

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy